Inspire Medical Systems (INSP) FCF Margin (2017 - 2026)

Inspire Medical Systems has disclosed FCF Margin across 10 years of filings, most recently posting 1.53% for Q1 2026.

• FCF Margin for Q1 2026 came in at 1.53%, up 648.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 13.69% (up 18.0% YoY), and the FY2025 annual result was 12.3%, down 350.0% from the prior year.
• FCF Margin came in at 1.53% for Q1 2026 at Inspire Medical Systems, down from 19.68% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 30.76% in Q3 2025 to a low of 20.12% in Q1 2022.
• The 5-year median for FCF Margin is 1.53% (2026), against an average of 5.85%.
• Across the five-year window, FCF Margin sank 1213 bps in 2023 and jumped 2812 bps in 2024, its largest moves.
• Inspire Medical Systems' FCF Margin stood at 16.93% in 2022, then slumped by 72 bps to 4.8% in 2023, then surged by 502 bps to 28.89% in 2024, then slumped by 32 bps to 19.68% in 2025, then sank by 92 bps to 1.53% in 2026.
• The last three FCF Margin figures came in at 1.53% (Q1 2026), 19.68% (Q4 2025), and 30.76% (Q3 2025), per Business Quant data.